OTC •
Healthcare •
Drug Manufacturers - General •
Quote as of 06/24/2026 10:03
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeOTC
Market Capitalization24,633 mln
Float1,791 mln
Earnings Date04/27/2026
EPS
1.01
Decent
P / E
13.08
Fair value
Piotroski F-Score
7
/ 9
Strong
Beneish M-Score
-2.64
Likely reliable
Relative Strength
33
/ 100
Underperforming
Debt / Equity
0.31
Low leverage
Business Description
Astellas Pharma is a Japanese pharmaceutical company founded in 1923 that develops and sells medicines across several major health areas, including cancer, kidney disease, eye conditions, and women's health. Its product portfolio includes treatments for prostate cancer, leukemia, bladder issues, menopause symptoms, and anemia, among others. The company also pursues external partnerships to expand its research capabilities, including work on next-generation RNA-based therapies and diabetes management tools.